T
Theravance Biopharma Inc
Q3 2025 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2025(ET)
Revenue
This quarter$20M
Analyst estimate$20M▲ +0.1%
Year ago (Sep '24)$17M▲ +18.5%
EPS
Turned profitable
This quarter$0.04
Analyst estimate-$0.13▲ +131.3%
Year ago (Sep '24)-$0.06
Revenue Growth Trajectory
+15%YoY
Last 6 quarters · 4 analysts